DaVita Inc. (DVA)
Operates dialysis centers providing kidney treatment for patients with chronic kidney failure.
$236.31+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+70.6%
The outlook
DVA is trading near its 52-week highs and above both its 50- and 200-day moving averages, showing strength in near-term momentum. Analyst sentiment is mixed at "Hold," with the average price target sitting roughly 12% below current levels. The stock carries a trailing P/E of 22.7 and reflects a bullish technical setup alongside cautious fundamental sentiment from coverage.
What’s behind the score
Analyst consensusHold — 2.8 avg of 7 analysts
Price trendAbove its 50- & 200-day averages
52-week range98% of the way from its 52-week low to high
Price targetAvg target -12% vs current price
Analyst price target
~12-month · 7 analysts$208.57average target-11.7% vs now
Now $236.31
Low $145.00High $270.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$15.17B
52-wk high
$239.64
52-wk low
$101.00
50-day avg
$213.41
200-day avg
$154.36
Trailing P/E
22.7